Skip to main content
. 2017 Nov 16;12(11):e0188262. doi: 10.1371/journal.pone.0188262

Table 1. Patients' characteristics.

UTI (n = 102) no UTI (n = 102) P-value
age (yr) 55.4±15.1 50.6±13.5 0.018a
weight (kg) 70.1±13.9 78.0±15.3 <0.001a
height (m) 165.5±8.5 173.5±10.2 <0.001a
BMI (kg/m2) 24.8 (17.3–40.6) 25.2 (17.1–47.5) 0.648c
sex (m/f) 20 (20%) / 82 (80%) 64 (63%) / 38 (37%) <0.001b
number of prior transplantations
 zero 84 (82%) 86 (84%) 0.803b
 one 16 (16%) 13 (13%)
 two 2 (2%) 3 (3%)
time from RTx until office presentation/UTI (months) 24.3 (0.8–307) 28.5 (0.4–279) 0.677c
preemptive transplantation 7 10 0.614b
living donor transplantation 25 (25%) 41 (40%) 0.024b
ESP 19 (19%) 9 (9%) 0.066b
ABOi 5 (5%) 8 (8%) 0.568b
cumulative time on dialysis (months) 60 (3–225) 52 (2–243) 0.134c
CIT (h) 8.5 (1.1–35.0) 8.0 (1.0–30.0) 0.213c
WIT (min) 30.5±8.6 31.6±7.6 0.320a
donor data
 donor age 50.4±17.9 52.9±12.8 0.251a
 donor sex (m/f) 61 (60%) / 41 (40%) 45 (44%) / 57 (56%) 0.035b

Variables are reported as absolute and relative frequencies, mean ± standard deviation or median (minimum-maximum);

a t-test for independent groups;

b Fisher's exact test;

c Mann-Whitney U test; all patients were Western European descent.

UTI, urinary tract infection; BMI, body mass index; RTx, renal transplantation; ESP, European Senior Program; ABOi, ABO incompatible; CIT, cold ischemic time; WIT, warm ischemic time.